The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Resin (Kayexalate-Sevelamer) lung
Publications
[Granulomatous lung disease induced by kayexalate inhalation during immunotherapy for metastatic melanoma].
Revue des maladies respiratoires 2021 May 20;; — 2021 May 20
Refractory hypoxemia due to sodium polystyrene sulfonate (kayexalate) aspiration.
Annals of the American Thoracic Society 2014 Jul;11;993-5 — 2014 Jul — 993-5
Sodium polystyrene sulfonate (Kayexalate) aspiration.
Diagnostic pathology 2008 Jun 17;3;27 — 2008 Jun 17 — 27
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
Journal of acquired immune deficiency syndromes (1999) 2007 May 01;45;34-42 — 2007 May 01 — 34-42
Kayexalate (sodium polystyrene sulfonate) aspiration.
Archives of pathology & laboratory medicine 2005 Jan;129;125 — 2005 Jan — 125
Sodium polystyrene sulfonate (kayexalate) aspiration: histologic appearance and infrared microspectrophotometric analysis of two cases.
Archives of pathology & laboratory medicine 1996 Oct;120;967-9 — 1996 Oct — 967-9